跳至主要内容
临床试验/EUCTR2010-022041-19-IT
EUCTR2010-022041-19-IT进行中(未招募)不适用

Effects of L-carnitine administration in patients with elevated Lp(a)levels. - ND

RostaQuo S.p.A.0 个研究点开始时间: 2010年11月2日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • age between 18 and 75 years •both sexes •Lp(a) > 35 mg/dl •LDL-C<190 mg/dl •TG < 500 mg/dl •informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • miocardic infarction, angina pectoris, stroke, coronary angioplasty or bypass 6 months before screening visit •history of liver patologies •history of chronic renal insufficiency •previous organ transplantation •previous alcohol or drug abuse •if diabetic, HbA1c=7% •hypersensitivity known or suspected to L-Carnitine and/or its derivatives •treatment with L-Carnitine and/or its derivatives during 3 months before the start of the study. •for female patients: pregnant status known or suspected, ongoing breast nursing.

研究者

相似试验